Pieris Pharmaceuticals Inc (PIRS)
15.95
-0.15
(-0.93%)
USD |
NASDAQ |
Nov 14, 16:00
15.69
-0.26
(-1.63%)
After-Hours: 20:00
Pieris Pharmaceuticals Cash and Short Term Investments (Quarterly): 19.73M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 19.73M |
| March 31, 2024 | 19.08M |
| December 31, 2023 | 26.37M |
| September 30, 2023 | 44.81M |
| June 30, 2023 | 54.88M |
| March 31, 2023 | 48.38M |
| December 31, 2022 | 59.17M |
| September 30, 2022 | 69.82M |
| June 30, 2022 | 80.94M |
| March 31, 2022 | 100.27M |
| December 31, 2021 | 117.76M |
| September 30, 2021 | 125.05M |
| June 30, 2021 | 119.10M |
| March 31, 2021 | 66.84M |
| December 31, 2020 | 70.44M |
| September 30, 2020 | 82.64M |
| June 30, 2020 | 77.21M |
| March 31, 2020 | 86.76M |
| December 31, 2019 | 104.15M |
| September 30, 2019 | 86.24M |
| June 30, 2019 | 99.68M |
| Date | Value |
|---|---|
| March 31, 2019 | 110.78M |
| December 31, 2018 | 128.11M |
| September 30, 2018 | 137.30M |
| June 30, 2018 | 150.98M |
| March 31, 2018 | 159.58M |
| December 31, 2017 | 72.63M |
| September 30, 2017 | 89.92M |
| June 30, 2017 | 50.33M |
| March 31, 2017 | 55.24M |
| December 31, 2016 | 29.36M |
| September 30, 2016 | 36.56M |
| June 30, 2016 | 40.37M |
| March 31, 2016 | 31.19M |
| December 31, 2015 | 29.35M |
| September 30, 2015 | 32.25M |
| June 30, 2015 | 10.03M |
| March 31, 2015 | 13.17M |
| September 30, 2014 | 0.0002M |
| June 30, 2014 | 0.0111M |
| March 31, 2014 | 0.0002M |
| December 31, 2013 | 0.0001M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
19.08M
Minimum
Mar 2024
125.05M
Maximum
Sep 2021
72.28M
Average
70.44M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 219.64M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |
| Theriva Biologics Inc | 16.59M |